Luminoah has raised $25 million in Series B financing to expand access to its FDA-cleared enteral feeding system and increase its manufacturing and distribution capabilities. Sandbox Clinical Ventures led the round, with participation from the Blue Venture Fund, GV, Sands Capital, Texas Medical Center Venture Fund, the CU Healthcare Innovation Fund, the American Gastroenterological Association GI Opportunity Fund, and existing investors.
The financing consists of $20 million in new equity capital and $5 million in previously issued convertible notes that converted as part of the transaction.
Luminoah will use the capital to expand distribution of Luminoah Flow through home medical equipment suppliers and health systems across the United States. The company also plans to increase production capacity, add manufacturing automation, and continue developing Luminoah Intelligence, its data platform for clinicians.
Luminoah Flow received FDA clearance in April 2026. The company subsequently completed an early-access program involving patients served by healthcare institutions in the Pacific Northwest and Southeast.
The system combines a pocket-sized rechargeable feeding pump, nutrition pouches, and a connected mobile application. It is designed to let people receive nutrition while moving through their daily routines rather than remaining close to a larger pump or equipment pole.
Feeding information is uploaded to the mobile app. When patients elect to share their data, clinicians can use Luminoah Intelligence to review delivered nutrition and obtain greater visibility into therapy outside clinical settings.
Founder and CEO Neal Piper created Luminoah after his son, Noah, required tube feeding during cancer treatment. Founded in 2020, the company is headquartered in Charlottesville, Virginia. It is hiring across engineering, operations, and commercial functions as it prepares for broader adoption.
KEY QUOTES:
For too long, families who depend on tube feeding have had to organize their lives around the pump. We built Luminoah so the technology could fit around their lives instead. Our family’s experience inspired a mission to make tube feeding simpler and give people greater freedom. With patients now using our technology and the support of exceptional investors, we’re ready to bring that vision to many more families.
Neal Piper, Founder and CEO of Luminoah
We’re thrilled to partner with Neal and the Luminoah team to transform enteral feeding. Inspired by his family’s experience, Neal and the team have developed a patient-first solution that supports more active lives, simplifies feeding, and enables remote tracking for better care. We’re excited to support their next chapter.
Scott Davis, Venture Partner at GV
Luminoah is poised to disrupt an outdated and burdensome standard of care in enteral nutrition. By combining compact pump design, a user-friendly interface, and real-time tracking, Luminoah Flow not only improves the patient experience but also directly combats the drivers of poor nutrition plan adherence, which can help prevent hospital readmissions, reduce costs, and free up valuable clinician time.
Tom Hawes, Managing Director at the Blue Venture Fund and Sandbox Clinical Ventures
Enteral nutrition has gone far too long without meaningful innovation. Luminoah is making nutrition therapy more portable, connected, and patient-centered while giving clinicians better information to guide care. That combination of clinical need, patient impact, and thoughtful innovation is exactly what we look for through the AGA GI Opportunity Fund.
Tom Serena, CEO of the American Gastroenterological Association
Early access showed us how Luminoah Flow fits into a patient’s daily routine. Reaching thousands of patients takes distribution partners, manufacturing at scale, and software clinicians will actually use. Our Series B financing enables us to focus on these key initiatives.
Garrett Marin, Chief Operating Officer of Luminoah

